In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d
- PMID: 39222506
- DOI: 10.7326/ANNALS-24-01752-JC
In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d
Abstract
Dulhunty JM, Brett SJ, De Waele JJ, et al; BLING III Study Investigators. Continuous vs intermittent β-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. JAMA. 12 June 2024. [Epub ahead of print.] 38864155.
Conflict of interest statement
Comment on
-
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.JAMA. 2024 Aug 27;332(8):629-637. doi: 10.1001/jama.2024.9779. JAMA. 2024. PMID: 38864155 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources